Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1989-06-21
1991-05-28
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514 24, 536 41, 536 181, 536 184, 536121, A01N 4500, A01N 4304, C07G 300, C07H 1524, C07H 1500, C07H 2300
Patent
active
050195689
ABSTRACT:
Disclosed are pharmaceutical compositions for enhancing human host resistance against opportunistic infection in an individual immunocompromised by an AIDS-related virus, consisting essentially of an anti-viral, anti-AIDS drug selected from the group consisting of ansamycin, ribavirin, dideoxycitidine, HPA-23, AL-721, foscarnet, and azidothymidine and a glycolipid compound consisting essentially of the formula: ##STR1## where: R.sup.1 is .alpha. or .beta.-D-1-thiomannopyranoside, .alpha. or .beta.-L-1-thiofucopyranoside.
REFERENCES:
patent: 4189471 (1980-02-01), Ponipom et al.
patent: 4228274 (1980-10-01), Ponpipom et al.
patent: 4229441 (1980-10-01), Bugianesi et al.
patent: 4259324 (1981-03-01), Ponpipom et al.
patent: 4301152 (1981-11-01), Ponpipom
patent: 4652553 (1987-03-01), Hagmann et al.
patent: 4652637 (1987-03-01), Hagmann et al.
Chemical and Engineering News; Dec. 8, 1986, pp. 7-12; Pagani.
Chem Abstracts, vol. 99, 1983, 122792z Ponpipom et al.
Chem Abstracts, vol. 90, 1979, 23588v Chabala et al.
Chem Abstracts, vol. 94, 1981, 180690x Merck.
Carbohydrate Res., vol. 67, pp. 55-63, 1978.
J. Med. Chem., vol. 23, pp. 1184-1188, 1980.
Can. J. Chem., vol. 58, pp. 214-220, 1980.
Chem Pharm Bull Jap., vol. 12, pp. 528-532, 1964.
P.N.A.S., vol. 78, pp. 7294-7298, 1981.
J. Med. Chem., vol. 15, No. 12, pp. 1284-1287, 1972.
J. Org. Chem., vol. 43, No. 14, pp. 2923-2925, 1978.
Surgery, vol. 92, No. 2, pp. 138-145, "Pros. for Control of Host Defenses", Computer Literature Search.
Infection, vol. 12, No. 3, pp. 230/182 to 234/86, 1984.
Durette Philippe L.
Hagmann William K.
Ponpipom Mitree M.
Criares Theodore J.
Friedman Stanley J.
Harbour John W.
Merck & Co. , Inc.
Pfeiffer Hesna J.
LandOfFree
Steroidal glycolipids as host resistance stimulators against vir does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroidal glycolipids as host resistance stimulators against vir, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroidal glycolipids as host resistance stimulators against vir will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36175